Peregrine Set to Join Russell 3000

Peregrine to Highlight Key Clinical Data From Four ASCO Presentations at Needham Healthcare Conference

Positive Phase II Lung Cancer Data to Be Presented at ASCO Support Recently Opened Registrational Phase IIb Trial for Bavituximab

Glioblastoma Multiforme Data From Peregrine's Novel Brain Cancer Therapy Cotara(R) to Be Reported at ASCO

Peregrine Pharmaceuticals to Present at the Needham & Company Ninth Annual Healthcare Conference

New Progression-Free Survival Data From Peregrine's Bavituximab in Phase II Refractory Breast Cancer Trial to Be Presented at ASCO

Phase II Advanced Breast Cancer Data to Be Presented at ASCO Highlight Promising Tumor Response and Progression-Free Survival Data With Peregrine's Bavituximab

Peregrine to Present Lung, Advanced Breast, and Brain Cancer Clinical Data at 2010 ASCO Annual Meeting

Peregrine Pharmaceuticals to Present at the Rodman & Renshaw Sixth Annual Global Investment Conference

Avid Bioservices to Highlight Integrated Commercial Manufacturing Capabilities at 2010 BIO International Convention